Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98M Sell
48,955
-1,070
-2% -$74.7K 1.85% 22
2026
Q1
$3.02M Sell
50,025
-800
-2% -$54.1K 1.58% 26
2025
Q4
$3.23M Sell
50,825
-1,385
-3% -$89.9K 1.59% 21
2025
Q3
$3.67M Sell
52,210
-1,260
-2% -$88.7K 1.82% 17
2025
Q2
$3.44M Buy
53,470
+95
+0.2% +$5.98K 1.86% 20
2025
Q1
$3.71M Buy
+53,375
New +$3.99M 2.08% 15

Other funds holding MAS

Lipe & Dalton's MAS Position: Q2 2026 in Review

Lipe & Dalton reduced its Masco (MAS) stake by 2.1% in Q2 2026, selling an estimated $74.7K and leaving 48,955 shares worth $3.98M. The position accounts for 1.85% of the portfolio, ranked #22.

Lipe & Dalton first reported a position in MAS in Q1 2025 and has held it in 6 quarters since. 920 funds tracked by Wall St. Rank hold MAS as of Q2 2026.

  • Lipe & Dalton held 48,955 shares of Masco worth $3.98M as of Q2 2026.
  • Lipe & Dalton sold 1,070 Masco shares in Q2 2026, an estimated $74.7K.
  • Masco made up 1.85% of Lipe & Dalton's portfolio in Q2 2026, its #22 holding.
  • Lipe & Dalton first reported a position in Masco in Q1 2025 and has held it in 6 quarters since.
  • 920 funds tracked by Wall St. Rank held Masco as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.